Australian owned & operated
Card Payments AvailableVisaMastercardApple Pay
Home/Shop/Retatrutide 30mg
Retatrutide 30mg lyophilised powder vial – Solatide Biosciences research peptide, not for human consumption

Images are for illustration purpose only

Retatrutide 30mg

8 Reviews

This listing is for 1 × Retatrutide 30mg vial only. Retatrutide is a triple agonist peptide activating GLP-1, GIP, and Glucagon receptors, supplied as a lyophilised powder for in-vitro laboratory and analytical research use only. Specifications include ≥99% purity and storage at -20°C (long-term).

Research Use Only: This product is strictly for laboratory research and is not intended for human or veterinary consumption, therapeutic use, diagnostic use, or clinical application.

Useful Resources: Concentration Calculator | Retatrutide Research Overview | What Is Retatrutide? | GLP-1 Research Overview | COA & Lab Testing


Current Batch
SB26X7A2-RET30Now Shipping

This batch has third party test results

4 Tests Available
Test Summary
Purity

Purity

99.52%

HPLC

Pass

Identity

Identity

Confirmed

LC-MS

Pass

Net Peptide Content

Net Peptide Content

30.82 mg

Pass

Fentanyl Screen

Fentanyl Screen

Not Detected

Safety screen

Pass

Verified by ILS Laboratories|ISO/IEC 17025 Accredited

Official COA Verification

Independent Lab Verification

Scan the QR code to verify this certificate directly on the ILS Laboratories secure portal.

Access Code
LH5VUJER
$259.95 AUD
Quantity
1

Product Overview

Understanding Retatrutide 30mg

Retatrutide 30mg is a triple agonist peptide targeting GLP-1, GIP, and Glucagon receptors, supplied as a single high-volume lyophilised analytical reference material for in-vitro laboratory and analytical use. The 30mg format is suited to extended laboratory study programmes requiring larger reconstitution volumes or multiple experimental runs. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.

Research Applications

•Triple GLP-1/GIP/Glucagon Receptor Binding Studies: Investigate simultaneous multi-receptor binding kinetics and downstream pathway activation in experimental models.
•High-Volume Multi-Pathway Research: Conduct extended incretin signalling studies across multiple experimental runs from a single high-volume vial.
•Comparative Triple vs Dual Agonist Studies: Compare Retatrutide triple agonism against Tirzepatide dual agonism in receptor pharmacology assays.
•Metabolic Signalling Pathway Investigations: Examine multi-receptor metabolic signalling consequences and downstream effector pathway analysis in vitro.
This analytical standard is strictly for in-vitro laboratory research use only.

Reviews

Customer Reviews

5.0
Based on 8 verified reviews
H
Henry
15/05/2026

Would return

Will buy again!

S
Sarah J
12/05/2026

Nice team

Nice team. I sent a question before ordering and got a normal human reply, which helped.

M
Mina
26/04/2026

Positive

Positive experience from me.

N
Nathan B
23/02/2026

GOOD!

Got my wholoe family onto it lol

W
Will S
11/02/2026

Worth using

Worth using if you care about price and clear communication.

Cart

0

Your cart is currently empty.